This article discusses the use of a medication kit at home for terminal symptoms. This innovation has been in place for more than two years at the Hospice of the Cleveland Clinic. There is no previously published information on this innovation in the literature.
Pritchard RS, Fisher ES, Teno JM, et al.: Influence of patient preferences and local health system characteristics on the place of death. SUPPORT Investigators: Study to understand prognoses and preferences for risks and outcomes of treatment. J American Geriatrics Society. 1998; 46(10): 1242-1250.
2.
Lichter I, Hunt E: The last 48 hours of life. J Palliative Care. 1990; 6(4): 7-15.
3.
Nelson KA, Walsh D, Brady D, et al.: The dying cancer patient. Seminars in Oncology. 2000; 27(1):1-7.
4.
Walsh D, Doona M, Molnar M, et al.: Symptom control in advanced cancer: Important drugs and routes of administration. Seminars in Oncology. 2000; 27(1): 69-83.
5.
Breda M, Bianchi M, Riapamonti C, et al.: Plasma morphine and morphine-6-glucuronide patterns in cancer patients after oral, subcutaneous, sublabial and rectal short-term administration. Int J Clin Pharmacol Res. 1991; 11(2): 93-97.
6.
McIver B, Walsh D, Nelson K.The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage. 1994; 9: 341-345.
7.
Neill PA, Morton PBStark, RD.Chlorpromazine: a specific effect on breathlessness?Br. J Clin Pharmacol. 1985; 19: 793-797.
